Ground breaking new interferon-free treatments that cure hepatitis C in over 90% of patients were listed on the PBS in March this year. This event will:

• Outline the global and national impact of hepatitis C on the public health of communities.
• Discuss transmission, testing and management of hepatitis C.
• Assess the suitability of the new DAAs for your patients based on side effects, drug interactions and precautions.
• Detail the monitoring requirements for people with hepatitis C.
• Understand the new guidelines in relation to section 85 and how to remotely consult with specialists when initiating hepatitis C treatment.
• Be aware of local services/ alternative models that can support and treat people with hepatitis C.

Hepatitis C New Treatments | Event invitation